Literature DB >> 22502685

Anatomical distribution of colorectal carcinoma in Iran: a retrospective 15-yr study to evaluate rightward shift.

Ramesh Omranipour1, Rana Doroudian, Habibollah Mahmoodzadeh.   

Abstract

BACKGROUND: Although more than two third of colorectal cancers are localized on the left side, recent studies suggest a right ward shift in anatomical distribution with increase in proximal colon cancers. The aim of the present study was to determine the anatomical distribution of colorectal cancer in a referral center over a 15 year period.
METHOD: Records of patients who underwent colectomy in the Cancer Institute of Iran from 1994 to 2009 were retrieved. Data including anatomical localization, year of diagnosis, patient age and gender, tumor histology and differentiation, and disease stage were extracted. Tumors located from the cecum to the distal transverse colon were classified as right side and those occurring from the splenic flexure to the descending colon as left-sided. Cancer of rectum and recto-sigmoid junction were considered as rectal cancers.
RESULTS: A total of 442 patients including 220 (49/8%) men and 222 (50/2%) women with mean age 53 were included. Most patients were in stages II and III (47.1% and 33% respectively). There were 157 (35.5 %) colon cancers and 285 (64.5%) rectal cancers. 43.3% of the colon cancers were right sided and 56.7% were left sided. There was no statistically significant increase in right sided cancer during the period of the study. There were no significant differences in age at diagnosis, gender, grade and stage of tumor between the right and the left sided cancers.
CONCLUSION: No proximal shift over time was identified in our study.

Entities:  

Mesh:

Year:  2012        PMID: 22502685     DOI: 10.7314/apjcp.2012.13.1.279

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  7 in total

Review 1.  Outcomes of surgical treatment of primary signet ring cell carcinoma of the colon and rectum: 22 cases reviewed with literature.

Authors:  Sedat Belli; Huseyin Ozgur Aytac; Erdal Karagulle; Hakan Yabanoglu; Fazilet Kayaselcuk; Sedat Yildirim
Journal:  Int Surg       Date:  2014 Nov-Dec

2.  Evaluation of the left-to-right shift of colon tumors in Iran: Is the trend changing?

Authors:  Seyed Mohammad Hossein Kashfi; Ehsan Nazemalhosseini Mojarad; Mohamad Amin Pourhoseingholi; Hamid Asadzadeh Aghdaei; Fakhrialsadat Anaraki; Mohammad Reza Zali
Journal:  J Res Med Sci       Date:  2015-10       Impact factor: 1.852

3.  Polyp detection rate and pathological features in patients undergoing a comprehensive colonoscopy screening.

Authors:  Hamid Asadzadeh Aghdaei; Ehsan Nazemalhosseini Mojarad; Sara Ashtari; Mohmad Amin Pourhoseingholi; Vahid Chaleshi; Fakhrosadat Anaraki; Mehrdad Haghazali; Mohammad Reza Zali
Journal:  World J Gastrointest Pathophysiol       Date:  2017-02-15

4.  Feasibility of Mass Screening for Colorectal Cancer Using Fecal Immunochemical Test in Iran.

Authors:  Farin Kamangar; Mahsa Mohebtash
Journal:  Arch Iran Med       Date:  2017-12-01       Impact factor: 1.354

5.  The application of current diagnostic protocols of patients with colon cancer in preparation for therapy.

Authors:  Zora Vukobrat-Bijedic; Azra Husic-Selimovic; Amela Sofic; Nina Bijedic; Bisera Gogov; Aleksandra Djuran; Amila Redzepovic; Aida Saray; Ivana Bjelogrlic
Journal:  Acta Inform Med       Date:  2012-12

6.  Characteristics of colorectal polyps and cancer; a retrospective review of colonoscopy data in iran.

Authors:  Alireza Delavari; Fatemeh Mardan; Hamideh Salimzadeh; Faraz Bishehsari; Pejman Khosravi; Maryam Khanehzad; Siavosh Nasseri-Moghaddam; Shahin Merat; Reza Ansari; Homayoon Vahedi; Bijan Shahbazkhani; Mehdi Saberifiroozi; Masoud Sotoudeh; Reza Malekzadeh
Journal:  Middle East J Dig Dis       Date:  2014-07

7.  Spatial modeling of colonic lesions with geographic information systems.

Authors:  Mohammad Hadi Imanieh; Ali Goli; Mohammad Hossein Imanieh; Bita Geramizadeh
Journal:  Iran Red Crescent Med J       Date:  2014-12-27       Impact factor: 0.611

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.